Changes in <i>DNMT1</i> expression as a marker of epigenetic regulation disturbanses in multiple sclerosis patients DOI

Evgenia A. Tsymbalova,

Ekaterina А. Chernyavskaya,

Darja Е. Ryzhkova

и другие.

Medical academic journal, Год журнала: 2024, Номер 23(3), С. 41 - 53

Опубликована: Март 29, 2024

BACKGROUND: Multiple sclerosis is a chronic neurodegenerative autoimmune disease characterized by the presence of foci inflammation and demyelination in central nervous system. The initiation pathological processes multiple caused complex interaction genetic factors, unfavorable environmental factors epigenetic influences. Progressive neurological symptoms axonal conduction disorders, death neurodestruction lead to significant decreased patients’ quality life disability. search for new markers improve diagnostic therapeutic methods, including taking into account background interactions, an urgent task. AIM: work was aimed study changes DNMT1 mRNA expression patients with different duration, analyze methylation promoter, compare level homocysteine content blood, polymorphic variants genes coding key folate cycle enzymes. MATERIALS AND METHODS: peripheral mononuclear blood cells assessed reversed transcription followed polymerase chain reaction. Fluorescent reaction methyl-sensitive analysis high-resolution melting curves used promoter. determined chemiluminescence immunoassay. real-time genotyping polymorphism genes; fluorescent probes LNA modifications were discriminate alleles. RESULTS: It has been shown that patients, those at onset disease, significantly lower than control group. No relationship found between decrease promoter methylation. Strong positive combined effects genotypes MTR A2756G MTHFR C677T on have shown. These findings suggest genetically features metabolism may contribute disruption regulation sclerosis. CONCLUSIONS: obtained results indicate promise research identifying causing Studying mechanisms contribution pathogenesis could be one possible ways approaches.

Язык: Английский

Epigenetic Modifications in Parkinson's Disease: A Critical Review DOI
Ravikant Sharma, Priya Bisht, Anuradha Kesharwani

и другие.

European Journal of Pharmacology, Год журнала: 2024, Номер 975, С. 176641 - 176641

Опубликована: Май 14, 2024

Язык: Английский

Процитировано

3

Environmental and Genetic Traffic in the Journey from Sperm to Offspring DOI Creative Commons
Pallav Sengupta, Sulagna Dutta, Fong Fong Liew

и другие.

Biomolecules, Год журнала: 2023, Номер 13(12), С. 1759 - 1759

Опубликована: Дек. 7, 2023

Recent advancements in the understanding of how sperm develop into offspring have shown complex interactions between environmental influences and genetic factors. The past decade, marked by a research surge, has not only highlighted profound impact paternal contributions on fertility reproductive outcomes but also revolutionized our comprehension unveiling parental factors sculpt traits successive generations through mechanisms that extend beyond traditional inheritance patterns. Studies are more susceptible to factors, especially during critical phases growth. While these broadly detrimental health, their effects acute periods. Moving immutable nature genome, epigenetic profile cells emerges as dynamic architecture. This flexibility renders it disruptions. primary objective this review is shed light diverse processes which agents affect male capacity. Additionally, explores consequences interactions, demonstrating can reverberate offspring. It encompasses direct changes well broad spectrum adaptations. By consolidating current empirically supported research, offers an exhaustive perspective interwoven trajectories environment, genetics, epigenetics elaborate transition from

Язык: Английский

Процитировано

8

Decoding the genetic landscape of autism: A comprehensive review DOI Open Access
Mohammed Al‐Beltagi,

Nermin Kamal Saeed,

Adel Salah Bediwy

и другие.

World Journal of Clinical Pediatrics, Год журнала: 2024, Номер 13(3)

Опубликована: Авг. 29, 2024

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by heterogeneous symptoms and genetic underpinnings. Recent advancements in epigenetic research have provided insights into the intricate mechanisms contributing to ASD, influencing both diagnosis therapeutic strategies.

Язык: Английский

Процитировано

2

Early life epigenetics and childhood outcomes: a scoping review DOI
Srirupa Hari Gopal, Theresa Alenghat, Mohan Pammi

и другие.

Pediatric Research, Год журнала: 2024, Номер unknown

Опубликована: Сен. 18, 2024

Язык: Английский

Процитировано

2

Revisiting epigenetic regulation in cancer: Evolving trends and translational implications DOI
Mohammad Afsar Khan, Dhruv Mishra, Ranjan Kumar

и другие.

International review of cell and molecular biology, Год журнала: 2024, Номер unknown, С. 1 - 24

Опубликована: Окт. 4, 2024

Язык: Английский

Процитировано

2

OVERVIEW OF MULTIPLE SCLEROSIS DOI Creative Commons

Alaa Ali Ahmad Al-Dawani,

Hussain Ali A Albakhite,

Ruoa Faisal Albunayyan

и другие.

Journal of Population Therapeutics and Clinical Pharmacology, Год журнала: 2023, Номер unknown

Опубликована: Янв. 1, 2023

Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS), characterized by immune-mediated assaults on myelin sheath. This autoimmune disorder primarily impacts young individuals and can result in permanent axonal degeneration. The manifestations of MS vary, encompassing relapsing-remitting MS, primary-progressive secondary-progressive MS. etiology stems from an immune dysfunction, culminating obliteration healthy cells. Therapeutic approaches for are geared towards averting exacerbations protracted functional deterioration, with diverse FDA-endorsed drugs stratified according to their efficacy relapse mitigation. precise origin remains elusive; nonetheless, immunomodulated genetic predisposition environmental factors postulated exert considerable influence its onset.

Язык: Английский

Процитировано

6

Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population DOI Creative Commons

Jeremy M. Bingen,

Lindsay V. Clark,

Mark R. Band

и другие.

Frontiers in Genetics, Год журнала: 2023, Номер 13

Опубликована: Янв. 4, 2023

Black and Hispanic American patients frequently develop earlier onset of multiple sclerosis (MS) a more severe disease course that can be resistant to modifying treatments. The objectives were identify differential methylation genomic DNA (gDNA) associated with susceptibility treatment responses in cohort MS from underrepresented minority populations. Patients controls non-inflammatory neurologic conditions consented enrolled under an IRB-approved protocol. Approximately 64% donors identified as or African 30% White, Hispanic-Latino. Infinium MethylationEPIC bead arrays utilized measure epigenome-wide gDNA whole blood. Data analyzed the presence absence adjustments for unknown covariates dataset, some which corresponded Global patterns strongest those probes showed relative demethylation loci lower M values. Pathway analysis revealed unexpected associations shigellosis amoebiasis. Enrichment over-representation enhancer regions under-representation promoters. In included treatments, 10 differentially methylated (DMR's) FDR <1E-77. Five these genes (ARID5B, BAZ2B, RABGAP1, SFRP2, WBP1L) are cancer risk cellular differentiation have not been previously studies. Hierarchical cluster multi-dimensional scaling at 147 within DMR's was sufficient differentiate controls. corrections treated dimethyl fumarate immune regulatory pathways regulate cytokine chemokine signaling, axon guidance, adherens junctions. These results demonstrate possible gastrointestinal pathogens regulation our patient cohort. This work further suggests analyses performed therapies. Because their high representation cohort, may specific relevance Americans.

Язык: Английский

Процитировано

5

Multi-omics in Human Disease Biomarker Discovery DOI

Prashant Kumar,

Swarna Kanchan, Minu Kesheri

и другие.

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

1

Himalayan phytochemicals and their role as epigenetic modulating agents in cancer, diabetes and neurodegenerative disorders DOI
Shubham Kumar,

Jasdeep Singh,

Vagish Dwibedi

и другие.

Vegetos, Год журнала: 2024, Номер unknown

Опубликована: Сен. 9, 2024

Язык: Английский

Процитировано

1

Different genome-wide DNA methylation patterns in CD4+ T lymphocytes and CD14+ monocytes characterize relapse and remission of multiple sclerosis: focus on GNAS DOI
Ivan Kiselev, О. Г. Кулакова, О. А. Батурина

и другие.

Multiple Sclerosis and Related Disorders, Год журнала: 2024, Номер 91, С. 105910 - 105910

Опубликована: Сен. 30, 2024

Язык: Английский

Процитировано

1